Ligand validation:4MIF

FDA: DIHYDROFLAVINE-ADENINE DINUCLEOTIDE

FDA is a Ligand Of Interest in 4MIF designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4MIF_FDA_D_801	98%	10%	0.065	0.988	1.96	2.29	9	20	1	0	100%	1
4MIF_FDA_A_801	97%	10%	0.071	0.986	2.2	2.08	14	16	1	0	100%	1
4MIF_FDA_B_801	96%	11%	0.074	0.986	1.55	2.56	9	24	1	0	100%	1
4MIF_FDA_C_801	94%	19%	0.088	0.988	1.41	2.05	10	13	1	0	100%	1
4MIG_FDA_D_801	99%	19%	0.043	0.98	1.6	1.84	11	9	3	0	100%	1
4OPD_FDA_B_501	100%	67%	0.02	0.995	0.55	0.71	-	1	2	0	100%	1
3UKF_FDA_B_600	100%	10%	0.026	0.995	2.22	2.05	19	19	0	0	100%	1
3TSH_FDA_A_601	100%	38%	0.04	0.992	1.03	1.38	3	6	3	0	100%	1
4MOR_FDA_B_801	100%	15%	0.037	0.989	1.83	1.96	12	19	1	0	100%	1
3ATR_FDA_A_501	100%	23%	0.039	0.986	1.34	1.81	5	16	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.